Skip to main content
Premium Trial:

Request an Annual Quote

GenapSys: Loretta Cecil, Fredrik Eliasson, Diana McKenzie,

GenapSys has appointed Loretta Cecil, Fredrik Eliasson, and Diana McKenzie to its board of directors.

Cecil is executive VP and general counsel at healthcare software firm Change Healthcare. Previously, she was senior VP of governance relations at McKesson and general counsel for McKesson Technology Solutions. She holds a JD from the University of North Carolina at Chapel Hill and a BA in political science and communication studies from the University of North Carolina at Greensboro.

Eliasson is executive VP and CFO at Change Healthcare. Previously, he held various roles, including executive VP, chief sales and marketing officer, and CFO, at CSX Corporation. He holds MBA and BA degrees from Virginia Commonwealth University.

McKenzie is the former chief information officer of Workday. Before that, she had the same role at Amgen, and prior to that, she held IT and other positions at Eli Lilly. She has a BS in computer information systems and computer technology from Purdue University.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.